Dr. Beatrice Perotti Named a Worldwide Who's Who Entrepreneur of the Year for Excellence in Pharmaceutical Consulting

    THOUSAND OAKS, CA, July 22, 2013 /24-7PressRelease/ -- Dr. Beatrice Perotti, President and Chief Executive Officer of Beatrice Perotti Inc., has been named a Worldwide Who's Who Professional of the Year in Pharmaceutical Consulting. While inclusion in the Worldwide Who's Who Registry is an honor, only a small selection of members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, years of service, and the credentials they have provided in association with their Worldwide Who's Who membership.

BEATRICE PEROTTI, INC, is a global biopharmaceutical consulting company that is based in Los Angeles. Dr. Perotti started the firm in 2006 after 12 years of product development experience in the pharmaceutical and biotech industry. Dr. Perotti held leadership positions in pharmacokinetics, product strategy/ early development, strategic business operations and finance at Pfizer and Amgen. Dr. Perotti is also a certified meeting facilitator and a Six Sigma Black Belt specializing in R&D quality and process improvement.

Dr. Perotti trained with Dr. Les Benet and graduated with PhD in Pharmaceutical Chemistry - Pharmacokinetics & Drug Metabolism from the University of California, San Francisco (UCSF), and with MBA from the University of California, Los Angeles (UCLA). Dr. Perotti also has a Project Management Certificate from the California Institute of Technology (CalTech). Dr. Perotti is Council Member of Accelerated Medical Research of the Myelin Research Foundation, AFPE Fellow, UCSC Undergraduate Chemistry Fellow, Mills College Scholar, Hong Kong Mills Club Scholarship, Warren Hellman Music Scholar, Sir Jack Cater Scholar for Hong Kong, Who's Who in Math and Engineering, Who's Who in Women in Science and World Wide Who's Who 2013 Entrepreneur of the Year in Pharmaceutical Consulting.

Dr. Perotti has been engaged in projects of the following nature: Preclinical and IND program design, analysis and operational management for biosimilar and biotech companies; Clinical program design and operational management for biosimilars companies; Preclinical program expert and clinical pharmacokinetics expert at FDA pre-IND and Phase 2 meetings for biosimilar, biotech and biopharmaceutical companies; Clinical development strategies for specialty products companies; Preclinical pharmacokinetics consultation for biotech and biopharmaceutical companies; Clinical pharmacokinetics consultation (through Phase 3) for biotech and biopharmaceutical companies; Outsourcing strategy for preclinical research and development for biosimilar and biopharmaceutical companies; Outsourcing strategy for clinical development for biosimilar, biotech, biopharmaceutical and nutritional companies; Outsourcing process and template developments for clinical operations for

biopharmaceutical companies; Outsourcing implementation and vendor management for biopharmaceutical companies; CRO and research institutions contract negotiation and management for biosimilar, biotech and biopharmaceutical companies; CRO discounts (re)negotiation for biotech and biopharmaceutical companies; Six-Sigma projects in R&D operations for biopharmaceutical companies; Business development for biotech companies. Investment opportunities evaluation for private equity companies - preclinical and clinical CRO acquisitions. Dr. Perotti can communicate in English, Mandarin Chinese and Cantonese, and works on opportunities in North America, South America, Europe, China and ASEAN countries.

Dr. Perotti presents frequently at international conferences and lectures at the University of California. Selective recent programs include the World Clinical Trial in China 2010, World Pharma Trials Asia 2010, 2nd Annual Exploratory Clinical Development World Americas 2009, Exploratory Clinical Development Congress USA 2008, and UCLA's Fiat Lux Drug Development Seminar Series in 2013, 2009 and 2008.

For more information about Beatrice Perotti Inc., visit www.beatriceperotti.com.

About Worldwide Who's Who
With over 500,000 members representing every major industry, Worldwide Who's Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Worldwide Who's Who employs similar public relations techniques to those utilized by Fortune 500 companies, making them cost-effective for members who seek to take advantage of its career enhancement and business advancement services.

Worldwide Who's Who membership provides individuals with a valuable third-party endorsement of their accomplishments, and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.

For more information, please visit http://www.worldwidewhoswho.com.

Contact:
Ellen Campbell
Director, Media Relations
[email protected]

# # #